Development of lactobionic acid conjugated-copper chelators as anticancer candidates for hepatocellular carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of lactobionic acid conjugated-copper chelators as anticancer candidates for hepatocellular carcinoma
Authors
Keywords
Copper chelation, Hepatocellular carcinoma, Copper deposition, Apoptosis, Hepatic targeting
Journal
Arabian Journal of Chemistry
Volume 14, Issue 7, Pages 103241
Publisher
Elsevier BV
Online
2021-06-12
DOI
10.1016/j.arabjc.2021.103241
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis and evaluation of novel thiosemicarbazone and semicarbazone analogs with both anti-proliferative and anti-metastatic activities against triple negative breast cancer
- (2021) Chengfeng Bai et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A mononuclear copper(II) complex containing benzimidazole and pyridyl ligands: Synthesis, characterization, and antiproliferative activity against human cancer cells
- (2019) Sedat Kacar et al. Arabian Journal of Chemistry
- Liver as a key organ in the supply, storage, and excretion of copper
- (2018) Eve A Roberts et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Copper deposition in focal nodular hyperplasia and inflammatory hepatocellular adenoma
- (2017) Vishal S Chandan et al. JOURNAL OF CLINICAL PATHOLOGY
- Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein Receptor
- (2017) Carlos A. Sanhueza et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- In vitro antitumor activity of water-soluble copper(I) complexes with diimine and monodentate phosphine ligands
- (2017) Marina Porchia et al. Arabian Journal of Chemistry
- Well-Defined Multivalent Ligands for Hepatocytes Targeting via Asialoglycoprotein Receptor
- (2016) Xiangang Huang et al. BIOCONJUGATE CHEMISTRY
- The rational design of specific SOD1 inhibitors via copper coordination and their application in ROS signaling research
- (2016) Xiongwei Dong et al. Chemical Science
- Novel 2-aminoimidazole-4-one complexes of copper(II) and cobalt(II): Synthesis, structural characterization and cytotoxicity
- (2016) Olga O. Krasnovskaya et al. Arabian Journal of Chemistry
- Elevated copper impairs hepatic nuclear receptor function in Wilson’s disease
- (2015) Clavia Ruth Wooton-Kee et al. JOURNAL OF CLINICAL INVESTIGATION
- Wilson's disease and other neurological copper disorders
- (2015) Oliver Bandmann et al. LANCET NEUROLOGY
- Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferation
- (2015) Jing Wang et al. Nature Chemistry
- Copper Signaling Axis as a Target for Prostate Cancer Therapeutics
- (2014) R. Safi et al. CANCER RESEARCH
- Copper is required for oncogenic BRAF signalling and tumorigenesis
- (2014) Donita C. Brady et al. NATURE
- Synthesis and antiproliferative activity of some steroidal thiosemicarbazones, semicarbazones and hydrozones
- (2014) Chunfang Gan et al. STEROIDS
- Advances in Copper Complexes as Anticancer Agents
- (2013) Carlo Santini et al. CHEMICAL REVIEWS
- Cysteine-Mediated Redox Signaling: Chemistry, Biology, and Tools for Discovery
- (2013) Candice E. Paulsen et al. CHEMICAL REVIEWS
- Redox cycling of endogenous copper by thymoquinone leads to ROS-mediated DNA breakage and consequent cell death: putative anticancer mechanism of antioxidants
- (2013) H Zubair et al. Cell Death & Disease
- Novel Chelators for Cancer Treatment: Where Are We Now?
- (2012) Angelica M. Merlot et al. ANTIOXIDANTS & REDOX SIGNALING
- Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: Lost and found
- (2012) Eirini I. Rigopoulou et al. AUTOIMMUNITY REVIEWS
- Glycomimetic Ligands for the Human Asialoglycoprotein Receptor
- (2012) Sreeman K. Mamidyala et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Novel Role for Copper in Ras/Mitogen-Activated Protein Kinase Signaling
- (2012) M. L. Turski et al. MOLECULAR AND CELLULAR BIOLOGY
- Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals
- (2011) Brett M. Paterson et al. CHEMICAL SOCIETY REVIEWS
- Pathology of the Liver in Copper Overload
- (2011) Melanie Johncilla et al. SEMINARS IN LIVER DISEASE
- Hepatocyte Targeting and Intracellular Copper Chelation by a Thiol-Containing Glycocyclopeptide
- (2010) Anaïs M. Pujol et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Affinity gradients drive copper to cellular destinations
- (2010) Lucia Banci et al. NATURE
- Copper Homeostasis: The Role of Cellular Transporters
- (2010) Edward D. Harris NUTRITION REVIEWS
- Design, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and liposomes for hepatocyte-specific targeting
- (2010) Gonçalo J. L. Bernardes et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Thiosemicarbazones: the new wave in cancer treatment
- (2009) Danuta S Kalinowski et al. Future Medicinal Chemistry
- Increasing Cu bioavailability inhibits A oligomers and tau phosphorylation
- (2009) P. J. Crouch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ligational behavior of thiosemicarbazone, semicarbazone and thiocarbohydrazone ligands towards VO(IV), Ce(III), Th(IV) and UO2(VI) ions: Synthesis, structural characterization and biological studies
- (2009) M. Shebl et al. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
- Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
- (2008) Anshul Gupte et al. CANCER TREATMENT REVIEWS
- Mechanisms for copper acquisition, distribution and regulation
- (2008) Byung-Eun Kim et al. Nature Chemical Biology
- Targeted Delivery of Macromolecular Drugs: Asialoglycoprotein Receptor (ASGPR) Expression by Selected Hepatoma Cell Lines used in Antiviral Drug Development
- (2008) Yan Li et al. Current Drug Delivery
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started